Target intelligence / Profile preview

Prothymosin alpha pseudogene 2 (PTMAP2)

Target
PTMAP2
Molecular classification
Other (Pseudogene)
01

Overview

Prothymosin alpha pseudogene 2 (PTMAP2) is a member of the human prothymosin alpha gene family, but it is classified as a processed pseudogene, not a functional gene or protein. PTMAP2 encodes a sequence very similar to that of the functional prothymosin alpha gene (PTMA) but contains subtle differences at two amino acid positions. Despite the presence of an intact open reading frame and regulatory sequences, there is no evidence that PTMAP2 is transcribed or translated into a functional protein in human tissues. Therefore, it is not considered a molecular target (such as a receptor, enzyme, or transporter), nor does it have established biological or disease-related functions, interact with drugs, or serve as a biomarker. Only the "parental" PTMA gene expresses the functional prothymosin alpha protein, which is involved in cell proliferation, apoptosis, chromatin remodeling, and immune modulation. PTMAP2, like other pseudogenes in the family, is generally not expressed and is considered non-functional in the context of biological or therapeutic targeting[2].

Other names
PTMAP2prothymosin alpha pseudogene 2

Beyond the preview

Go deeper on Prothymosin alpha pseudogene 2 (PTMAP2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Prothymosin alpha pseudogene 2 (PTMAP2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call